Phyllis Chew
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
- Atherosclerosis and Cardiovascular Diseases 1
-
- Helminth infection and control 1
- Co-authors
- Karin Jandeleit‐Dahm (5 shared papers)Mark E. Cooper (6 shared papers)Harald Schmidt (4 shared papers)Stephen P. Gray (3 shared papers)Rhian M. Touyz (3 shared papers)Kit Kennedy (3 shared papers)Judy B. de Haan (3 shared papers)Derek Y.C. Yuen (2 shared papers)
- Journals
- Diabetologia (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Kidney International (1 paper)Clinical Science (1 paper)Nephrology (1 paper)
- Partner nations
- AustraliaNetherlandsUnited Kingdom
In The Last Decade
Phyllis Chew
9 papers receiving 574 citations
Peers
Comparison fields: 5 of 69
- Clinical Biochemistry 97
- Immunology 178
- Nephrology 55
- Physiology 143
- Biochemistry 41
Countries citing papers authored by Phyllis Chew
This map shows the geographic impact of Phyllis Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Chew more than expected).
Fields of papers citing papers by Phyllis Chew
This network shows the impact of papers produced by Phyllis Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Chew. The network helps show where Phyllis Chew may publish in the future.
Co-authors
The 25 scholars most cited alongside Phyllis Chew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 157 | |
| 2 | 2010 | 112 | |
| 3 | 2017 | 94 | |
| 4 | 2009 | 81 | |
| 5 | 2013 | 54 | |
| 6 | 2016 | 31 | |
| 7 | 2010 | 28 | |
| 8 | A comparative trial of albendazole, mebendazole, pyrantel pamoate and oxantel pyrantel pamoate against soil-transmitted helminthiases in school children. | 1990 | 13 |
| 9 | 2019 | 7 |
About Phyllis Chew
Phyllis Chew is a scholar working on Immunology, Small Animals, Molecular Biology, Nephrology and Toxicology, having authored 9 papers that have together received 577 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Parasites and Host Interactions (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Helminth infection and control (1 paper) and Organoselenium and organotellurium chemistry (1 paper). The work is most often cited by research in Clinical Biochemistry (97 citations), Immunology (178 citations), Nephrology (55 citations), Physiology (143 citations) and Biochemistry (41 citations). Phyllis Chew has collaborated with scholars based in Australia, Netherlands and United Kingdom. Frequent co-authors include Karin Jandeleit‐Dahm, Mark E. Cooper, Harald Schmidt, Stephen P. Gray, Rhian M. Touyz, Kit Kennedy, Judy B. de Haan, Derek Y.C. Yuen, Nada Stefanovic and Elyse Di Marco. Their work appears in journals such as Diabetologia, Arteriosclerosis Thrombosis and Vascular Biology, Kidney International, Clinical Science and Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.